Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing skin and easing symptom severity in patients with plaque psoriasis. Johnson ...

Using coronary artery calcium (CAC) scoring to guide treatment in intermediate-risk patients, as opposed to usual care, results in a slower development of atherosclerotic plaque, including high-risk ...

And every year, even as guests shuffle out of the venue, one of the art deco columns that they pass will already be adorned with a plaque noting that year’s winner. Displaying every honoree of ...